MicroRNA-210 Enhances Cell Survival and Paracrine Potential for Cardiac Cell Therapy While Targeting Mitophagy.

Area of Science:

• Cardiovascular Biology
• Regenerative Medicine
• Cellular Metabolism

Background:

• Cardiac progenitor cells (CPCs) show therapeutic promise for heart regeneration but face survival challenges in vivo.
• Clinical trial efficacy is limited by poor CPC survival, retention, and expansion.
• Hypoxic preconditioning may enhance CPC survival and regenerative capacity.

Purpose of the Study:

• To investigate the role of microRNA-210 (miR-210) in enhancing CPC survival and function under hypoxic stress.
• To elucidate the mechanisms by which miR-210 impacts CPC apoptosis, metabolism, and paracrine signaling.
• To assess the potential of miR-210 to improve CPC-based myocardial repair therapies.

Main Methods:

• Overexpression of miR-210 in CPCs.
• Assessment of apoptosis markers (caspase activity, DNA fragmentation, Casp8ap2 expression).
• Analysis of mitophagy markers (Bnip3) and mitochondrial biogenesis.
• Measurement of paracrine factor secretion (SCF, IGF-1).
• In vitro assays for endothelial cell proliferation and cardiomyocyte survival.

Main Results:

• miR-210 significantly inhibited CPC apoptosis by downregulating Casp8ap2, reducing caspase activity and DNA fragmentation.
• miR-210 did not induce Bnip3-dependent mitophagy; instead, it reduced mitophagy markers and enhanced mitochondrial biogenesis and oxidative metabolism.
• miR-210 increased secretion of stem cell factor (SCF) and insulin growth factor 1 (IGF-1) by ~1.6-fold.
• Secreted factors promoted endothelial cell proliferation and cardiomyocyte survival in vitro.

Conclusions:

• miR-210 plays a multifaceted role in CPC biology, enhancing survival through anti-apoptotic and metabolic reprogramming pathways.
• miR-210 promotes CPC-mediated cardiac repair by improving cell survival, metabolic fitness, and paracrine signaling.
• Targeting miR-210 represents a promising strategy to enhance the efficacy of cell-based therapies for myocardial regeneration.